CARDIOVAX

Serial Number 86796602
Registration 4977539
701

Registration Progress

Application Filed
Oct 22, 2015
Under Examination
Approved for Publication
Mar 29, 2016
Published for Opposition
Mar 29, 2016
Registered
Jun 14, 2016

Attorney Assistance

Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20160614)
Due: Jun 14, 2026 127 days

Trademark Image

CARDIOVAX

Basic Information

Serial Number
86796602
Registration Number
4977539
Filing Date
October 22, 2015
Registration Date
June 14, 2016
Published for Opposition
March 29, 2016
Drawing Code
5

Status Summary

Current Status
Active
Status Code
701
Status Date
Jan 31, 2023
Registration
Registered
Classes
005 042

Rights Holder

ABCENTRA

16
Address
1925 CENTURY PARK EAST, SUITE 1700
LOS ANGELES, CA 90067

Ownership History

CardioVax

Original Applicant
16
Torrance, CA

CardioVax

Owner at Publication
16
Torrance, CA

CardioVax

Original Registrant
16
Torrance, CA

ABCENTRA

New Owner After Registration #1
16
LOS ANGELES, CA

Legal Representation

Attorney
A. Tally Eitan

USPTO Deadlines

Next Deadline
127 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20160614)
Due Date
June 14, 2026
Grace Period Ends
December 14, 2026

Application History

15 events
Date Code Type Description Documents
Jun 14, 2025 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jan 31, 2023 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Loading...
Jan 31, 2023 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED Loading...
Jan 31, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jul 24, 2022 ES8R I TEAS SECTION 8 RECEIVED Loading...
Jun 14, 2021 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Aug 26, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 14, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 29, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 29, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 9, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 16, 2016 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 12, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 27, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 26, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medications that are immune therapies for treating cardiovascular and other diseases; vaccines
First Use Anywhere: Sep 29, 2015
First Use in Commerce: Sep 29, 2015
Class 042
Medical, pharmaceutical, biotech and clinical research and development of medications that are immune therapies for treating cardiovascular and other diseases
First Use Anywhere: Nov 26, 2014
First Use in Commerce: Nov 26, 2014

Additional Information

Design Mark
The mark consists of the word "CARDIOVAX" in stylized writing.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042